1. The 1000 Genomes Project Consortium. A global reference for human genetic variation.
Nature. 2015;526:68–74.
2. Mallick S, Li H, Lipson M, Mathieson I, Gymrek M, Racimo F, et al. The Simons Genome
Diversity Project: 300 genomes from 142 diverse populations. Nature. 2016;538:201–6.
3. Pagani L, Lawson DJ, Jagoda E, Mörseburg A, Eriksson A, Mitt M, et al. Genomic
analyses inform on migration events during the peopling of Eurasia. Nature. 2016;538:238–42.
4. Walter K, Min JL, Huang J, Crooks L, Memari Y, McCarthy S, et al. The UK10K project
identifies rare variants in health and disease. Nature. 2015;526:82–9.
5. Delaneau O, Marchini J, Zagury J. A linear complexity phasing method for thousands
of genomes. Nat. Methods. 2011;9:179–81.
6. Sawyer S, Hartl DL. Population Genetics of Polymorphism and Divergence. Genetics.
1992;132:1161–76.
7. Felsenstein J, Churchill GA. A Hidden Markov Model Approach Evolution. Mol. Biol.
Evol. 1996;13:93–104.
8. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily
conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15:1034–50.
9. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A. Distribution and
intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15:901–13.
10. Veltman J a., Brunner HG. De novo mutations in human genetic disease. Nat. Rev.
Genet. 2012;13:565–75.
11. Jin Z-B, Wu J, Huang X-F, Feng C-Y, Cai X-B, Mao J-Y, et al. Trio-based exome
sequencing arrests de novo mutations in early-onset high myopia. Proc. Natl. Acad.
Sci. 2017;114:4219–24.
12. Yuen RKC, Merico D, Cao H, Pellecchia G, Alipanahi B, Thiruvahindrapuram B, et
al. Genome-wide characteristics of de novo mutations in autism. Genomic Med. 2016;1:doi:10.1038/npjgenmed.2016.27.
13. Al-Mubarak B, Abouelhoda M, Omar A, Aldhalaan H, Aldosari M, Nester M, et al.
Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder:
A trio study from Saudi families. Sci. Rep. 2017;7:5679.
14. Hai DT, Thanh ND, Trang PTM, Quang LS, Hang PTT, Cuong DC, et al. Whole genome
analysis of a Vietnamese trio. J. Biosci. 2015;40:113–24.
15. Besenbacher S, Liu S, Izarzugaza JM, Grove J, Belling K, Bork-jensen J, et al.
Novel variation and de novo mutation rates in population-wide de novo assembled Danish
trios. Nat. Commun. 2015;6:5969.
16. Combrink HJB, Soderberg C, Boutin ME, Boutin AY, Wise MR, Zook M. Indigenous Groups
of Sabah: An Annotated Bibliography of Linguistic and Anthropological Sources. 2nd
editio. Sabah: SIL International; 2008.
17. Deng L, Hoh BP, Lu D, Fu R, Phipps ME, Li S, et al. The population genomic landscape
of human genetic structure, admixture history and local adaptation in Peninsular Malaysia.
Hum. Genet. 2014;133:1169–85.
18. Liu X, Yunus Y, Lu D, Aghakhanian F, Saw WY, Deng L, et al. Differential positive
selection of malaria resistance genes in three indigenous populations of Peninsular
Malaysia. Hum. Genet. 2015;134:375–92.
19. Deng L, Hoh B-P, Lu D, Saw W-Y, Twee-Hee Ong R, Kasturiratne A, et al. Dissecting
the genetic structure and admixture of four geographical Malay populations. Sci. Rep.
2015;5:14375.
20. Yew CW, Minsong A, Tiek S, Lau Y, Pugh-kitingan J, Ransangan J, et al. Genetic
relatedness of indigenous ethnic groups in northern Borneo to neighboring populations
from Southeast Asia , as inferred from genome-wide SNP data. Ann. Hum. Genet. 2018;doi.org/10.1111/ahg.12246.
21. Consortium THP-ASNP, Abdulla M a, Ahmed I, Assawamakin a, Bhak J, Brahmachari
SK, et al. Mapping Human Genetic Diversity in Asia. Science. 2009;326:1541–5.
22. Fu R, Mokhtar SS, Phipps ME, Hoh B-P, Xu S, Shuhada S, et al. A genome-wide characterization
of copy number variations in native populations of Peninsular Malaysia. Eur. J. Hum.
Genet. 2018;26:247–57.
23. Yew C, Lu D, Wong L, Twee-Hee Ong R, Lu Y, Wang X, et al. Genomic structure of
the native inhabitants of Peninsular Malaysia and North Borneo suggests complex human
population history in Southeast Asia. Hum. Genet. 2018;137:161–73.
24. Schneider VA, Graves-Lindsay T, Howe K, Bouk N, Chen HC, Kitts PA, et al. Evaluation
of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality
of the reference assembly. Genome Res. 2017;27:849–64.
25. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence
Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
26. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The
Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing
data. Genome Res. 2010;20:1297–303.
27. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate
of de novo mutations and the importance of father-s age to disease risk. Nature. 2012;488:471–5.
28. Neale B, Kou Y, Liu L, Ma’ayan A, Samocha K, Sabo A, et al. Patterns and rates
of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485:242–6.
29. Abyzov A, Urban AE, Snyder M, Gerstein M. CNVnator: An approach to discover, genotype,
and characterize typical and atypical CNVs from family and population genome sequencing.
Genome Res. 2011;21:974–84.
30. Zhu M, Need AC, Han Y, Ge D, Maia JM, Zhu Q, et al. Using ERDS to infer copy-number
variants in high-coverage genomes. Am. J. Hum. Genet. 2012;91:408–21.
31. Trost B, Walker S, Wang Z, Thiruvahindrapuram B, MacDonald JR, Sung WWL, et al.
A Comprehensive Workflow for Read Depth-Based Identification of Copy-Number Variation
from Whole-Genome Sequence Data. Am. J. Hum. Genet. 2018;102:142–55.
32. MacDonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW. The Database of Genomic Variants:
A curated collection of structural variation in the human genome. Nucleic Acids Res.
2014;42:986–92.
33. Kehr B, Melsted P, Halldórsson B V. PopIns: Population-scale detection of novel
sequence insertions. Bioinformatics. 2016;32:961–7.
34. Prüfer K, Racimo F, Patterson N, Jay F, Sankararaman S, Sawyer S, et al. The complete
genome sequence of a Neanderthal from the Altai Mountains. Nature. 2014;505:43–9.
35. Meyer M, Kircher M, Gansauge M-T, Li H, Racimo F, Mallick S, et al. A high-coverage
genome sequence from an archaic Denisovan individual. Science. 2012;338:224–6.
36. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for
annotating and predicting the effects of single nucleotide polymorphisms, SnpEff.
Fly (Austin). 2012;6:80–92.
37. Huang DW, Lempicki R a, Sherman BT. Systematic and integrative analysis of large
gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44–57.
38. Wong L-P, Ong RT-H, Poh W-T, Liu X, Chen P, Li R, et al. Deep whole-genome sequencing
of 100 southeast Asian Malays. Am. J. Hum. Genet. The American Society of Human Genetics;
2013;92:52–66.
39. Wong LP, Lai JKH, Saw WY, Ong RTH, Cheng AY, Pillai NE, et al. Insights into the
Genetic Structure and Diversity of 38 South Asian Indians from Deep Whole-Genome Sequencing.
PLoS Genet. 2014;10:e1004377.
40. Silver KL, Zhong K, Leke RGF, Taylor DW, Kain KC. Dysregulation of angiopoietins
is associated with placental malaria and low birth weight. PLoS One. 2010;5:e9481.
41. Pozzoli U, Fumagalli M, Cagliani R, Comi GP, Bresolin N, Clerici M, et al. The
role of protozoa-driven selection in shaping human genetic variability. Trends Genet.
2010;26:95–9.
42. Ravenhall M, Campino S, Sepúlveda N, Manjurano A, Nadjm B, Mtove G, et al. Novel
genetic polymorphisms associated with severe malaria and under selective pressure
in North-eastern Tanzania. PLoS Genet. 2018;14:e1007172.
43. Athanasiu L, Giddaluru S, Fernandes C, Christoforou A, Reinvang I, Lundervold
AJ, et al. A genetic association study of CSMD1 and CSMD2 with cognitive function.
Brain. Behav. Immun. 2017;61:209–16.
44. Pelak K, Shianna K V., Ge D, Maia JM, Zhu M, Smith JP, et al. The characterization
of twenty sequenced human genomes. PLoS Genet. 2010;6:e1001111.
45. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, et al.
A systematic survey of loss-of-function variants in human protein-coding genes. Science.
2012;205:823–8.
46. Garcîa G, Pêrez AB, Sierra B, Aguirre E, Kikuchi M, Sânchez L, et al. Association
of MICA and MICB alleles with symptomatic dengue infection. Hum. Immunol. 2011;72:904–7.
47. Gambelunghe G, Gerli R, Bocci EB, Sindaco P Del, Ghaderi M, Sanjeevi CB, et al.
Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility
for systemic lupus erythematosus. Rheumatology. 2005;44:287–92.
48. Acuna-Hidalgo R, Veltman JA, Hoischen A. New insights into the generation and
role of de novo mutations in health and disease. Genome Biol. 2016;17:1–19.
49. Lin Q, Huang Y, Booth CJ, Haase VH, Johnson RS, Celeste Simon M, et al. Activation
of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy.
J. Am. Heart Assoc. 2013;2:1–23.
50. Parsa A, Chang YPC, Kelly RJ, Corretti MC, Ryan KA, Robinson SW, et al. Hypertrophy-associated
polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.
Clin. Transl. Sci. 2011;4:17–23.
51. Maretty L, Jensen JM, Petersen B, Sibbesen JA, Liu S, Villesen P, et al. Sequencing
and de novo assembly of 150 genomes from Denmark as a population reference. Nature.
2017;548:87–91.
52. Ramu A, Noordam MJ, Schwartz RS, Wuster A, Hurles ME, Cartwright RA, et al. DeNovoGear:
De novo indel and point mutation discovery and phasing. Nat. Methods. 2013;10:985–7.
53. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, et al. Genome-wide
scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure
determination in two European populations. Hum. Mol. Genet. 2009;18:2288–96.
54. Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M. Adiponectin receptors, with special
focus on the role of the third receptor, T-cadherin, in vascular disease. Med. Mol.
Morphol. 2007;40:115–20.
55. Dastani Z, Hivert MF, Timpson N, Perry JRB, Yuan X, Scott RA, et al. Novel loci
for adiponectin levels and their influence on type 2 diabetes and metabolic traits:
A multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8.
56. Band G, Le QS, Jostins L, Pirinen M, Kivinen K, Jallow M, et al. Imputation-Based
Meta-Analysis of Severe Malaria in Three African Populations. PLoS Genet. 2013;9:e1003509.
57. Grant GD, Brooks L, Zhang X, Mahoney JM, Martyanov V, Wood TA, et al. Identification
of cell cycle – regulated genes periodically expressed in U2OS cells and their regulation
by FOXM1 and E2F transcription factors. Mol. Biol. Cell. 2013;24:3634–50.
58. Hollox EJ, Hoh B-P. Human gene copy number variation and infectious disease. Hum.
Genet. 2014;133:1217–33.
59. Walker S, Janyakhantikul S, Armour JAL. Multiplex Paralogue Ratio Tests for accurate
measurement of multiallelic CNVs. Genomics. 2009;93:98–103.
60. Hollox EJ, Armour JAL, Barber JCK. Extensive Normal Copy Number Variation of a
β-Defensin Antimicrobial-Gene Cluster. Am. J. Hum. Genet. 2003;73:591–600.
61. MacHado LR, Hardwick RJ, Bowdrey J, Bogle H, Knowles TJ, Sironi M, et al. Evolutionary
history of copy-number-variable locus for the low-affinity Fcγ receptor: Mutation
rate, autoimmune disease, and the legacy of helminth infection. Am. J. Hum. Genet.
2012;90:973–85.
62. Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, Redon R, et al. Diet and the
evolution of human amylase gene copy number variation. Nat. Genet. 2007;39:1256–60.
63. Zheng X, Feingold E, Ryckman KK, Shaffer JR, Boyd HA, Feenstra B, et al. Association
of maternal CNVs in GSTT1/GSTT2 with smoking, preterm delivery, and low birth weight.
Front. Genet. 2013;4:doi: 10.3389/fgene.2013.00196.
64. Emeville E, Broquère C, Brureau L, Ferdinand S, Blanchet P, Multigner L, et al.
Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean
population of African descent. PLoS One. 2014;9:e107275.
65. Noureen A, Fresser F, Utermann G, Schmidt K. Sequence variation within the KIV-2
copy number polymorphism of the human LPA gene in African, Asian, and European populations.
PLoS One. 2015;10:e0121582.
66. Wu Z, Sheng H, Chen Y, Tang J, Liu Y, Chen Q, et al. Copy number variation of
the Lipoprotein ( a ) ( LPA ) gene is associated with coronary artery disease in a
southern Han Chinese population. Int. J. Clin. Exp. Med. 2014;7:3669–77.
67. Beoris M, Amos Wilson J, Garces JA, Lukowiak AA. CYP2D6 copy number distribution
in the US population. Pharmacogenet. Genomics. 2016;26:96–9.
68. Hollox EJ, Huffmeier U, Zeeuwen PLJM, Palla R, Lascorz J, Rodijk-Olthuis D, et
al. Psoriasis is associated with increased β-defensin genomic copy number. Nat. Genet.
2008;40:23–5.
69. Haridan US, Mokhtar U, Machado LR, Aziz ATA, Shueb RH, Zaid M, et al. A comparison
of assays for accurate copy number measurement of the low-affinity FC gamma receptor
genes FCGR3A and FCGR3B. PLoS One. 2015;10:e0116791.
70. Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, Van Schoot E Der, et
al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but
not FCGR2A and FCGR2B. Hum. Mutat. 2009;30:E640-50.
71. Vendelbosch S, de Boer M, Gouw RATW, Ho CKY, Geissler J, Swelsen WTN, et al. Extensive
Variation in Gene Copy Number at the Killer Immunoglobulin-Like Receptor Locus in
Humans. PLoS One. 2013;8:e67619.
72. Bustamante CD, Burchard EG, De la Vega FM. Genomics for the world. Nature. 2011;475:163–5.
73. Ségurel L, Wyman MJ, Przeworski M. Determinants of Mutation Rate Variation in
the Human Germline. Annu. Rev. Genomics Hum. Genet. 2014;1–24.
74. Mills MB, Hudgins L, Balise RR, Abramson DH, Kleinerman R a. Mutation risk associated
with paternal and maternal age in a cohort of retinoblastoma survivors. Hum. Genet.
2012;131:1115–22.
75. Gillies RJ, Verduzco D, Gatenby RA. Evolutionary dynamics of carcinogenesis and
why targeted therapy does not work. Nat. Rev. Cancer. 2012;12:487–93.
76. Browning SR, Browning BL. Haplotype phasing: Existing methods and new developments.
Nat. Rev. Genet. 2011;12:703–14.
77. Zhang F, Deng HW. Confounding from cryptic relatedness in haplotype-based association
studies. Genetica. 2010;138:945–50.